Biolog-id develops value-chain optimisation solutions that create, collect, and consolidate high-quality data to drive operational, commercial, and clinical impact for high-value health products. The platform's smart management solution targets delicate healthcare products and was rolled out following a $33 million raise in 2019. Founded in 2005, the company plans to accelerate commercial expansion and penetrate adjacent healthcare verticals. Management said the new funding will inject additional value into the solution and optimise the platform for growth opportunities. The $25 million investment from private equity firm Xerys Invest is intended to boost global expansion and expedite entry into new markets, with Xerys's chairman noting the solution's global potential and commercial realisation.

Total raised

$25M

Funding rounds

1

Latest round

Equity

Latest activity

May 2022